Myocardial tissue ablation with narrow temperature variation
US-12042215-B2 · Jul 23, 2024 · US
US12343059B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12343059-B2 |
| Application number | US-202017096043-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 12, 2020 |
| Priority date | Nov 25, 2019 |
| Publication date | Jul 1, 2025 |
| Grant date | Jul 1, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein is a vapor therapy device for producing intra-uterine tissue effects. The device can include a shaft, including a proximal portion and a distal portion, a fluid-expandable medium, near the distal portion of the shaft, a fluid-delivery conduit, extending between the proximal portion and the distal portion of the shaft, the fluid-delivery conduit comprising an outlet, near the distal portion of the shaft, for delivery of the fluid toward the medium, and an in vivo heat generator, near the distal portion of the shaft, to heat the fluid. A method of treating a patient for menorrhagia with the device can include introducing a medium, in a contracted state, into a patient, delivering a fluid toward the medium to expand the medium in vivo; generating heat in vivo on or near the medium to vaporize the fluid, and exposing a treatment site to the vaporized fluid.
Opening claim text (preview).
The claimed invention is: 1. A vapor therapy device for producing intra-uterine tissue effect, for at least partial insertion into a patient, the device comprising: a shaft, including a proximal portion and a distal portion; an in vivo heat generator, near the distal portion of the shaft; a fluid-expandable medium, near the distal portion of the shaft, and fully sheathing the in vivo heat generator, wherein the fluid-expandable medium comprises: a pressure barrier layer encompassing an outlet of a fluid-delivery conduit; a transport layer at least partially encompassing the pressure barrier layer; and a tissue compliant layer at least partially surrounding the transport layer; the fluid-delivery conduit, extending between the proximal portion and the distal portion of the shaft, the fluid-delivery conduit comprising the outlet, near the distal portion of the shaft, for providing fluid into the fluid-expandable medium, wherein the in vivo heat generator is configured to heat the fluid inside the fluid-expandable medium. 2. The device of claim 1 , wherein the in vivo heat generator is configured to vaporize the fluid in vivo. 3. The device of claim 1 , further comprising a valve in fluid communication with the fluid-delivery conduit, wherein the valve is configured to be user-controlled to control delivery of the fluid towards the medium via the valve. 4. The device of claim 1 , wherein the fluid-expandable medium is permeable to vapor. 5. The device of claim 1 , wherein the fluid-expandable medium has a porosity that increases when expanded. 6. The device of claim 1 , wherein the fluid-expandable medium comprises a balloon. 7. The device of claim 1 , wherein the fluid-expandable medium comprises a sponge. 8. The device of claim 1 , wherein the fluid-expandable medium comprises a relatively compressed state for insertion into the patient and is capable of expanding to a relatively expanded state. 9. The device of claim 8 , wherein the relatively compressed state comprises a diameter of less than about 6 mm for insertion. 10. The device of claim 8 , wherein the relatively expanded state comprises a diameter of about 6 cm to about 9 cm when expanded. 11. The device of claim 1 , wherein the transport layer has a porosity greater than the pressure barrier layer and wherein the tissue compliant layer has a porosity greater than the transport layer. 12. The device of claim 1 , wherein the transport layer has a higher heat capacity than the pressure barrier layer, and wherein the tissue compliant layer has a higher heat capacity than the transport layer. 13. The device of claim 1 , wherein the fluid-expandable medium includes a more thermally conductive region that is more distal to the outlet than a less thermally conductive region of the fluid-expandable medium. 14. The device of claim 1 , wherein the fluid-expandable medium includes reduced thermal conductivity portions configured to be located toward respective fallopian tubes in the patient. 15. The device of claim 1 , wherein the in vivo heat generator is configured to produce heat by passing a current through a resistor. 16. The device of claim 1 , wherein the outlet is located in the fluid-expandable medium. 17. The device of claim 1 , wherein the pressure barrier layer maintains a pressure threshold to prevent premature expansion of the fluid-expandable medium when the fluid is provided into the fluid-expandable medium. 18. The device of claim 1 , wherein the pressure layer, the transport layer, and the tissue compliant layer comprise a hardness measure indicating greater resistance to indentation. 19. The device of claim 18 , wherein the hardness measure increases from the pressure layer toward the tissue compliant layer.
in gaseous form · CPC title
Ablation · CPC title
Female reproductive organs · CPC title
Balloons · CPC title
low, i.e. thermally insulating · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.